GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hana Pharm Co Ltd (XKRX:293480) » Definitions » Research & Development

Hana Pharm Co (XKRX:293480) Research & Development : ₩8,984 Mil (TTM As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Hana Pharm Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Hana Pharm Co's Research & Development for the three months ended in Dec. 2024 was ₩2,273 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was ₩8,984 Mil.


Hana Pharm Co Research & Development Historical Data

The historical data trend for Hana Pharm Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hana Pharm Co Research & Development Chart

Hana Pharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only 3,241.97 3,489.31 4,748.28 7,404.00 8,984.47

Hana Pharm Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,796.49 1,667.56 2,069.59 2,974.09 2,273.24

Hana Pharm Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩8,984 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hana Pharm Co  (XKRX:293480) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Hana Pharm Co Research & Development Related Terms

Thank you for viewing the detailed overview of Hana Pharm Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Hana Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
218 Teheran-ro, 15 Floor, 16 Floor, Narae Building, Gangnam-gu, Seoul, KOR
Hana Pharm Co Ltd is a Korea based company engaged in drug development. It offers products for anesthetics, narcotic analgesics, antiemetics, antibiotics, dermatology, urinology, osteoporosis, and central nervous system.

Hana Pharm Co Headlines

No Headlines